Breaking News Instant updates and real-time market news.

ZYNE

Zynerba

$12.61

-0.31 (-2.40%)

07:13
05/31/19
05/31
07:13
05/31/19
07:13

Zynerba remains 'potentially dramatically undervalued,' says H.C. Wainwright

H.C. Wainwright analyst Oren Livnat says that even with the stock up 324% year-to-date, shares of Zynerba Pharmaceuticals remain "potentially dramatically undervalued." The analyst continues to entirely value the company on the opportunity in Fragile X Syndrome, and he expects Zynerba to soon announce CONNECT-FX Phase 3 enrollment completion which would put the company on track for transformative topline data in Q4. He projects peak U.S. sales of $700M and keeps a Buy rating on the shares with a $23 price target.

  • 04

    Jun

  • 11

    Jun

ZYNE Zynerba
$12.61

-0.31 (-2.40%)

05/08/19
05/08/19
NO CHANGE

Zynerba reports Q1 EPS (47c), consensus (49c)
04/30/19
ROTH
04/30/19
INITIATION
Target $36
ROTH
Buy
Zynerba initiated with a Buy at Roth Capital
Roth Capital analyst Jerry Isaacson started Zynerba Pharmaceuticals with a Buy rating and $36 price target, telling investors that while the company's lead Fragile X Syndrome program is valuable, Zynerba's pipeline programs have more potential value. The next program in development is for developmental and epileptic encephalopathy, noted Isaacson, who values the potential of Zygel for the treatment of FXS at $5 per share and for DEE at $28 per share.
04/22/19
ADAM
04/22/19
INITIATION
Target $18
ADAM
Buy
Zynerba assumed with a Buy at Canaccord
Canaccord analyst Sumant Kulkarni assumed coverage of Zynerba Pharmaceuticals with a Buy rating and $18 price target. In a research note to investors, Kulkarni says he believes Zynerba, with Zygel's multiple shots on goal, presents significant opportunity for risk-tolerant investors heading into key events, including data for an open-label Phase 2 trial in developmental and epileptic encephalopathies in the third quarter of 2019, and data for a trial for Fragile X syndrome in the second half of the year.
09/21/18
CANT
09/21/18
INITIATION
Target $21
CANT
Overweight
Zynerba initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Charles Duncan last night initiated coverage of Zynerba with an Overweight rating and $21 price target. The analyst, who started coverage on seven Neuro-Innovator and Platform-Enabled Therapeutic companies, believes that "biotech has entered a golden age of innovation and productivity across many therapeutic areas."

TODAY'S FREE FLY STORIES

XNCR

Xencor

$33.86

-1.31 (-3.72%)

, HF

HFF Inc.

$45.25

-0.29 (-0.64%)

17:22
06/24/19
06/24
17:22
06/24/19
17:22
Hot Stocks
Xencor to replace HFF Inc. in S&P 600 at open on 7/2 »

Jones Lang LaSalle (JLL)…

XNCR

Xencor

$33.86

-1.31 (-3.72%)

HF

HFF Inc.

$45.25

-0.29 (-0.64%)

JLL

Jones Lang LaSalle

$137.43

-2.075 (-1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 06

    Aug

  • 26

    Aug

USNA

Usana

$72.41

-0.58 (-0.79%)

, LION

Fidelity Southern

$30.18

-0.06 (-0.20%)

17:20
06/24/19
06/24
17:20
06/24/19
17:20
Hot Stocks
Usana to replace Fidelity Southern in S&P 600 at open on 7/1 »

Ameris Bancorp (ABCB) is…

USNA

Usana

$72.41

-0.58 (-0.79%)

LION

Fidelity Southern

$30.18

-0.06 (-0.20%)

ABCB

Ameris Bancorp

$37.76

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLAB

Mesa Labs

$227.44

-3.4 (-1.47%)

, AAXN

Axon

$73.22

-0.12 (-0.16%)

17:19
06/24/19
06/24
17:19
06/24/19
17:19
Hot Stocks
Breaking Hot Stocks news story on Mesa Labs, Axon »

Mesa Labs to replace Axon…

MLAB

Mesa Labs

$227.44

-3.4 (-1.47%)

AAXN

Axon

$73.22

-0.12 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAXN

Axon

$73.22

-0.12 (-0.16%)

, MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

17:18
06/24/19
06/24
17:18
06/24/19
17:18
Hot Stocks
Breaking Hot Stocks news story on Axon, MarketAxess »

Axon to replace…

AAXN

Axon

$73.22

-0.12 (-0.16%)

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

, LLL

L3 Technologies

$256.30

(0.00%)

17:18
06/24/19
06/24
17:18
06/24/19
17:18
Hot Stocks
MarketAxess to replace L3 Technologies in S&P 500 at open on 7/1 »

Harris (HRS) is acquiring…

MKTX

MarketAxess

$332.76

-0.24 (-0.07%)

LLL

L3 Technologies

$256.30

(0.00%)

HRS

Harris

$197.28

-0.07 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VGZ

Vista Gold

$0.81

-0.0026 (-0.32%)

17:04
06/24/19
06/24
17:04
06/24/19
17:04
Hot Stocks
Vista Gold CFO Jack Engele to retire, Douglas Tobler to succeed »

Vista Gold is pleased to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$198.60

-0.17 (-0.09%)

17:03
06/24/19
06/24
17:03
06/24/19
17:03
Periodicals
Apple to announce Seattle expansion on Monday, Seattle Times reports »

According to a story by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPE

HP Enterprise

$15.00

0.07 (0.47%)

, CRWD

Crowdstrike

$67.91

-5.09 (-6.97%)

17:01
06/24/19
06/24
17:01
06/24/19
17:01
Hot Stocks
HP Enterprise appoints Crowdstrike CEO George Kurtz to Board of Directors »

Hewlett Packard…

HPE

HP Enterprise

$15.00

0.07 (0.47%)

CRWD

Crowdstrike

$67.91

-5.09 (-6.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

  • 09

    Jul

NGM

NGM Biopharmaceuticals

$13.88

0.1 (0.73%)

17:01
06/24/19
06/24
17:01
06/24/19
17:01
Initiation
NGM Biopharmaceuticals initiated  »

NGM Biopharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNDA

Vanda Pharmaceuticals

$13.81

-0.27 (-1.92%)

17:00
06/24/19
06/24
17:00
06/24/19
17:00
Hot Stocks
Armistice Capital reports 6.2% passive stake in Vanda Pharmaceuticals »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

CBAY

CymaBay

$6.76

-0.32 (-4.52%)

16:58
06/24/19
06/24
16:58
06/24/19
16:58
Initiation
CymaBay initiated  »

CymaBay initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PK

Park Hotels & Resorts

$27.47

-0.73 (-2.59%)

16:58
06/24/19
06/24
16:58
06/24/19
16:58
Hot Stocks
Park Hotels & Resorts announces sale of three non-core assets for $166M »

Park Hotels & Resorts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICPT

Intercept

$79.64

-1.74 (-2.14%)

16:56
06/24/19
06/24
16:56
06/24/19
16:56
Initiation
Intercept initiated  »

Intercept initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRYS

Krystal Biotech

$41.15

11.87 (40.54%)

16:48
06/24/19
06/24
16:48
06/24/19
16:48
Syndicate
Krystal Biotech files to sell $100M of common stock »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

GNFT

Genfit

$20.19

-0.02 (-0.10%)

16:40
06/24/19
06/24
16:40
06/24/19
16:40
Hot Stocks
Breaking Hot Stocks news story on Genfit »

Genfit SA (ADS) trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:40
06/24/19
06/24
16:40
06/24/19
16:40
General news
Fed's Kaplan wants to take more of a wait-and-see approach to policy »

Fed's Kaplan wants…

CHWY

Chewy

$31.52

-0.64 (-1.99%)

16:38
06/24/19
06/24
16:38
06/24/19
16:38
Hot Stocks
Lone Pine Capital reports 6.1% passive stake in Chewy »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARQL

ArQule

$10.00

-0.48 (-4.58%)

16:38
06/24/19
06/24
16:38
06/24/19
16:38
Syndicate
ArQule files to sell common stock, no amount given »

SVB Leerink and RBC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLXT

Calyxt

$12.55

-0.43 (-3.31%)

16:35
06/24/19
06/24
16:35
06/24/19
16:35
Hot Stocks
Calyxt enters commercial crushing agreement with Landus Cooperative »

Calyxt announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

CNAT

Conatus

$0.94

0.0019 (0.20%)

16:35
06/24/19
06/24
16:35
06/24/19
16:35
Hot Stocks
Breaking Hot Stocks news story on Conatus 

Conatus trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

GNFT

Genfit

$20.19

-0.02 (-0.10%)

16:34
06/24/19
06/24
16:34
06/24/19
16:34
Hot Stocks
Terns announces licensing, collaboration agreement with Genfit »

Terns Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EHC

Encompass Health

$61.64

-0.305 (-0.49%)

16:34
06/24/19
06/24
16:34
06/24/19
16:34
Hot Stocks
Encompass Health makes investment in Medalogix »

Encompass Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHS

Chico's

$3.33

-0.065 (-1.92%)

16:32
06/24/19
06/24
16:32
06/24/19
16:32
Hot Stocks
Chico's FAS board approves amendment to company bylaws over share acquisition »

Chico's FAS issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBNK

Territorial Bancorp

$27.87

-0.12 (-0.43%)

16:31
06/24/19
06/24
16:31
06/24/19
16:31
Hot Stocks
Territorial Bancorp declares special mid-year cash dividend of 10c per share »

Payable on July 22 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARQL

ArQule

$10.00

-0.48 (-4.58%)

16:31
06/24/19
06/24
16:31
06/24/19
16:31
Syndicate
Breaking Syndicate news story on ArQule »

ArQule files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.